BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3255872)

  • 1. Severe ischemic process in a young man with central retinal vein occlusion.
    Chen V; Moisseiev J; Treister G
    Metab Pediatr Syst Ophthalmol (1985); 1988; 11(1-2):67-9. PubMed ID: 3255872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neovascular glaucoma--etipathogeny and diagnosis].
    Călugăru D; Călugăru M
    Oftalmologia; 2012; 56(2):3-14. PubMed ID: 23424756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular neovascularization associated with central and hemicentral retinal vein occlusion.
    Hayreh SS; Zimmerman MB
    Retina; 2012 Sep; 32(8):1553-65. PubMed ID: 22495331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capillary macroaneurysms in central retinal vein occlusion.
    Battaglia Parodi M; Bondel E; Ravalico G
    Ophthalmologica; 1995; 209(5):248-50. PubMed ID: 8570146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracameral bevacizumab for iris rubeosis.
    Grisanti S; Biester S; Peters S; Tatar O; Ziemssen F; Bartz-Schmidt KU;
    Am J Ophthalmol; 2006 Jul; 142(1):158-60. PubMed ID: 16815268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dilation of the minor arterial circle of the iris preceding rubeosis iridis during retinal vein occlusion.
    Paques M; Girmens JF; Rivière E; Sahel J
    Am J Ophthalmol; 2004 Dec; 138(6):1083-6. PubMed ID: 15629321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab as adjuvant for neovascular glaucoma.
    Beutel J; Peters S; Lüke M; Aisenbrey S; Szurman P; Spitzer MS; Yoeruek E; ; Grisanti S
    Acta Ophthalmol; 2010 Feb; 88(1):103-9. PubMed ID: 18811641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Panretinal cryopexy for the management of neovascularization of the iris.
    Stefaniotou M; Paschides CA; Psilas K
    Ophthalmologica; 1995; 209(3):141-4. PubMed ID: 7543193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral rubeosis iridis and rubeotic glaucoma due to peripheral occlusive vasculitis associated with multiple sclerosis.
    Turner SJ; Dharmasena A; Deane J
    Ocul Immunol Inflamm; 2011 Oct; 19(5):373-5. PubMed ID: 21895514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases].
    Douat J; Auriol S; Mahieu-Durringer L; Ancèle E; Pagot-Mathis V; Mathis A
    J Fr Ophtalmol; 2009 Nov; 32(9):652-63. PubMed ID: 19892433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central retinal vein occlusion: the therapeutic options.
    Madhusudhana KC; Newsom RS
    Can J Ophthalmol; 2007 Apr; 42(2):193-5. PubMed ID: 17392840
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of central retinal venous pressure in patients with central retinal vein occlusion and a high mean area of nonperfusion.
    McAllister IL; Tan MH; Smithies LA; Wong WL
    Ophthalmology; 2014 Nov; 121(11):2228-36. PubMed ID: 25037752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential diagnosis of spontaneous hyphema associated with central retinal vein occlusion.
    Terry JE; Roberts DK
    J Am Optom Assoc; 1986 Sep; 57(9):688-92. PubMed ID: 2430005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neovascular glaucoma due to branch retinal vein occlusion combined with branch retinal artery occlusion.
    An TS; Kwon SI
    Korean J Ophthalmol; 2013 Feb; 27(1):64-7. PubMed ID: 23372385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neovascular glaucoma associated with cilioretinal artery occlusion combined with perfused central retinal vein occlusion.
    Seo MS; Woo JM; Seo JJ
    Jpn J Ophthalmol; 2002; 46(2):198-202. PubMed ID: 12062227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone implants and neovascular glaucoma in central retinal vein occlusion.
    Joshi L; Tomkins-Netzer O; Menezo V; Sallam A; Kirkpatrick N; Lightman S; Taylor SR
    Acta Ophthalmol; 2013 May; 91(3):e239-40. PubMed ID: 23241218
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the clinical course of central retinal vein occlusion in eyes with and without glaucoma.
    Vadalà G; Zanini A; Favero C; Brogliatti B; Boles Carenini B
    Acta Ophthalmol Scand Suppl; 1997; (224):16-7. PubMed ID: 9589710
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical features of central retinal vein occlusion complicating exudative retinal detachment].
    Peng XY; Wang JZ; Li ZH; Chen JT
    Zhonghua Yan Ke Za Zhi; 2006 Jun; 42(6):492-5. PubMed ID: 16857126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iris neovascularization and neovascular glaucoma in neurofibromatosis type 1: report of 3 cases in children.
    Al Freihi SH; Edward DP; Nowilaty SR; Abouammoh MA; Morales J
    J Glaucoma; 2013; 22(4):336-41. PubMed ID: 22138687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.